Avery Dennison Corporation’s AVY Vancive Medical Technologies business, in association with Becton, Dickinson and Company BDX (BD), has launched a line of transparent vascular dressings with chlorhexidine gluconate (CHG) antimicrobial preservative. The dressings will enhance patient care and aid easy application and removal for clinicians.
The combination of BD’s vascular access expertise, infection prevention expertise from the CareFusion acquisition and CHG adhesive technology from Avery Dennison’s Vancive Medical Technologies will create a powerful solution for a new vascular access product.
The new BD ChloraShield dressings, which feature BeneHold CHG, an innovative adhesive technology from Vancive Medical Technologies, comfortably secure the dressing to the skin, absorbing fluids and protecting the area from external contaminants. The CHG incorporated within the adhesive preserves the dressing from microbial growth, making them apt for catheter insertion sites.
This collaboration brings together complementary expertise from both companies. BD ChloraShield dressings are available in a variety of designs including bordered and non-bordered as well as sizes commonly used for peripheral IVs and PICCs.
BD and Vancive Medical Technologies will showcase the new BD ChloraShield dressings in booth #423 at the 30th annual Association for Vascular Access Conference, being held from Sep 16−19 in Orlando, FL.
Notably, Avery Dennison’s Vancive Medical Technologies business reported solid margin expansion in the second quarter of 2016. The company remains focused on its product pipeline and recently reestablished the organizational link between its Vancive and performance tapes business.
In the long term, these actions, combined with strong growth from the new product platform, should help to deliver consistent organic growth and double-digit margins in this business.
Avery Dennison currently holds a Zacks Rank #2 (Buy).
Other well-ranked stocks in the same sector include ACCO Brands Corporation ACCO and AO Smith Corp. AOS, both carrying the same Zacks Rank as Avery Dennison. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Confidential from Zacks
Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.